Cancelled Preliminary Injunction in Zeltiq-CLINIPRO Court Case
Court decides to withdraw injunction against LipoCryo in Spain

BARCELONA, Spain, July 3, 2012 /PRNewswire/ -- CLINIPRO, Spanish manufacturer of medical-aesthetic devices announces that as a result of the lawsuit filed by Zeltiq Aesthetics Inc. (Nasdaq: ZLTQ) along with the Massachusetts General Hospital (MGH) against CLINIPRO for alleged patent infringement, the Barcelona Mercantile Court no.5 issued an Order dated June 25, 2012, accepting the provision of an alternative security by CLINIPRO which substitutes preliminary injunction agreed at previous Order of May 5, 2012 preventing any act of marketing the LipoCryo device in Spain.

On the occasion of prior Order of May 5, 2012, Zeltiq issued several releases, causing confusion in the industry and among public opinion, stating that all LipoCryo devices sold in Spain had been withdrawn from the market -something that never happened- and that the same would happen in other countries where LipoCryo is being marketed successfully.

Now the situation is clear because according to the Order of June, 5, 2012, CLINIPRO can continue manufacturing, offering, advertising and marketing the LipoCryo device in Spain without any restriction and without involving any infringement neither for the manufacturer nor for the distributor.

Internationally, CLINIPRO will continue to market LipoCryo as done before, because the Order that had been issued never produced effects outside Spain.

Through this release, CLINIPRO intends to reiterate its conviction that MGH patent is not being infringed and that this will be demonstrated in the act of the oral trial, which has been set for next September.

About CLINIPRO

Clinipro is a company with presence in over 40 countries and its vision is to remain being the benchmark and the effective, secure and non-invasive alternative to surgical treatments of aesthetic medicine. Always aimed at offering the latest technology and staying ahead of market trends to provide the most innovative technologies. Clinipro, with 20 years of industry experience, has professional technicians and highly qualified physicians that support their brands results such as LipoCryo and Mesostar, among others, which contribute to people's physical well being through safe and effective procedures.

More information
Mireia Dalmau
Mireia.dalmau@clinipro.net
+34 935 903 108

SOURCE CLINIPRO

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here